633-65-8 | 16,17-dimethoxy-5,7-dioxa-13$l^{5}-azapentacyclo[11.8.0.0^{2,10}.0^{4,8}.0^{15,20}]henicosa-1(13),2,4(8),9,14,16,18,20-octaen-13-ylium chloride

Packsize	Purity	Availability	Price	Discounted Price
250mg	97%	in stock	$15.00	$10.00
1g	97%	in stock	$16.00	$11.00
5g	97%	in stock	$19.00	$13.00
25g	97%	in stock	$49.00	$34.00
100g	97%	in stock	$105.00	$74.00
500g	97%	in stock	$322.00	$225.00

Description

• Catalog Number: AI54108
• Chemical Name: 16,17-dimethoxy-5,7-dioxa-13$l^{5}-azapentacyclo[11.8.0.0^{2,10}.0^{4,8}.0^{15,20}]henicosa-1(13),2,4(8),9,14,16,18,20-octaen-13-ylium chloride
• CAS Number: 633-65-8
• Molecular Formula: C20H22ClNO6
• Molecular Weight: 407.8448
• MDL Number: MFCD00149998
• SMILES: COc1c(OC)ccc2c1c[n+]1CCc3c(-c1c2)cc1c(c3)OCO1.[Cl-].O.O

Computed Properties

• Complexity: 488
• Covalently-Bonded Unit Count: 2
• Heavy Atom Count: 26
• Hydrogen Bond Acceptor Count: 5
• Rotatable Bond Count: 2

Literature

• Non-nucleoside reverse transcriptase inhibitor (NNRTI) cross-resistance: implications for preclinical evaluation of novel NNRTIs and clinical genotypic resistance testing.

  The Journal of antimicrobial chemotherapy 20140101

• Structural optimization of berberine as a synergist to restore antifungal activity of fluconazole against drug-resistant Candida albicans.

  ChemMedChem 20140101

• Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.

  Bioorganic & medicinal chemistry 20121115

• Synthesis, structure-activity relationship and in vitro anti-mycobacterial evaluation of 13-n-octylberberine derivatives.

  European journal of medicinal chemistry 20120601

• Synthesis of novel 9-O-N-aryl/aryl-alkyl amino carbonyl methyl substituted berberine analogs and evaluation of DNA binding aspects.

  Bioorganic & medicinal chemistry 20120415

• Benzenediol-berberine hybrids: multifunctional agents for Alzheimer's disease.

  Bioorganic & medicinal chemistry 20111201

• Quinolino-benzo-[5, 6]-dihydroisoquindolium compounds derived from berberine: a new class of highly selective ligands for G-quadruplex DNA in c-myc oncogene.

  European journal of medicinal chemistry 20110501

• Differential gene expression in rat vascular smooth muscle cells following treatment with coptisine exerts a selective antiproliferative effect.

  Journal of natural products 20110425

• Synthesis of 9-substituted derivatives of berberine as anti-HIV agents.

  European journal of medicinal chemistry 20110401

• Synthesis, biological evaluation and molecular modeling of novel triazole-containing berberine derivatives as acetylcholinesterase and β-amyloid aggregation inhibitors.

  Bioorganic & medicinal chemistry 20110401

• Berberine derivatives, with substituted amino groups linked at the 9-position, as inhibitors of acetylcholinesterase/butyrylcholinesterase.

  Bioorganic & medicinal chemistry letters 20101115

• Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

  Bioorganic & medicinal chemistry letters 20101101

• Design, synthesis, and cholesterol-lowering efficacy for prodrugs of berberrubine.

  Bioorganic & medicinal chemistry 20100901

• Benzylisoquinoline alkaloids from the tubers of Corydalis ternata and their cytotoxicity.

  Bioorganic & medicinal chemistry letters 20100801

• Synthesis and biological evaluation of a new series of berberine derivatives as dual inhibitors of acetylcholinesterase and butyrylcholinesterase.

  Bioorganic & medicinal chemistry 20100615

• Synthesis, anticancer and antioxidant activities of 7-methoxyisoflavanone and 2,3-diarylchromanones.

  European journal of medicinal chemistry 20100601

• Inhibitors of prolyl oligopeptidases for the therapy of human diseases: defining diseases and inhibitors.

  Journal of medicinal chemistry 20100513

• Synthesis, biological evaluation, and molecular modeling of berberine derivatives as potent acetylcholinesterase inhibitors.

  Bioorganic & medicinal chemistry 20100201

• Synthesis and biological evaluation of berberine analogues as novel up-regulators for both low-density-lipoprotein receptor and insulin receptor.

  Bioorganic & medicinal chemistry letters 20091101

• Structure-activity relationship of isoform selective inhibitors of Rac1/1b GTPase nucleotide binding.

  Bioorganic & medicinal chemistry letters 20091001

• Antibacterial activity of berberine-NorA pump inhibitor hybrids with a methylene ether linking group.

  Bioorganic & medicinal chemistry 20090601

• Probing of the cis-5-phenyl proline scaffold as a platform for the synthesis of mechanism-based inhibitors of the Staphylococcus aureus sortase SrtA isoform.

  Bioorganic & medicinal chemistry 20090401

• Synthesis and structure-activity relationships of novel, substituted 5,6-dihydrodibenzo[a,g]quinolizinium P2X7 antagonists.

  Bioorganic & medicinal chemistry letters 20090201

• Berberine analogues as a novel class of the low-density-lipoprotein receptor up-regulators: synthesis, structure-activity relationships, and cholesterol-lowering efficacy.

  Journal of medicinal chemistry 20090122

• Synthesis and structure-activity relationships of berberine analogues as a novel class of low-density-lipoprotein receptor up-regulators.

  Bioorganic & medicinal chemistry letters 20080815

• Structure-activity relationships of 2-aryl-1H-indole inhibitors of the NorA efflux pump in Staphylococcus aureus.

  Bioorganic & medicinal chemistry letters 20080801

• Antioxidant and cytotoxic activities of canadine: biological effects and structural aspects.

  Bioorganic & medicinal chemistry 20080401

• Aaptamines as sortase A inhibitors from the tropical sponge Aaptos aaptos.

  Bioorganic & medicinal chemistry letters 20071001

• Antiviral activity of berberine and related compounds against human cytomegalovirus.

  Bioorganic & medicinal chemistry letters 20070315

• Synthesis of 13-(substituted benzyl) berberine and berberrubine derivatives as antifungal agents.

  Bioorganic & medicinal chemistry letters 20060801

• Phytochemistry and antifungal properties of the newly discovered tree Pleodendron costaricense.

  Journal of natural products 20060701

• Microsphere-based protease assays and screening application for lethal factor and factor Xa.

  Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

• Synthesis and antihyperglycemic evaluation of various protoberberine derivatives.

  Bioorganic & medicinal chemistry letters 20060301

• Metabolites of the 'smoke tree', Dalea spinosa, potentiate antibiotic activity against multidrug-resistant Staphylococcus aureus.

  Journal of natural products 20060201

• A new glucosyl feruloyl quinic acid as a potential marker for roots and rhizomes of goldenseal, Hydrastis canadensis.

  Journal of natural products 20041101

• Xanthones and benzophenones from the stems of Garcinia multiflora.

  Journal of natural products 20030801

• Antitubercular natural products: berberine from the roots of commercial Hydrastis canadensis powder. Isolation of inactive 8-oxotetrahydrothalifendine, canadine, beta-hydrastine, and two new quinic acid esters, hycandinic acid esters-1 and -2.

  Journal of natural products 19981001

• Evaluation of natural products as inhibitors of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase.

  Journal of natural products 19910101